Egyptian Liver Journal

Table 7 Comparison between each group before and after treatment and the two studied groups according to fasting blood sugar

From: Impact of direct-acting antiviral therapy on metabolic profiles and adiponectin serum level in different categories of patients with chronic hepatitis C infection

FBS (mmol/L)	Groups		T test
FBS (mmol/L)	Group I	Group II	t	P value
Before
Range	3.8–6.7 mmol/L	4.2–6.5 mmol/L	1.953	0.054*
Man ± SD	5.448 ± 0.771 mmol/L	5.176 ± 0.613 mmol/L	1.953	0.054*
After
Range	4.3–6.7 mmol/L	4.3–6.2 mmol/L	0.827	0.410
Mean ± SD	5.290 ± 0.602 mmol/L	5.204 ± 0.422 mmol/L	0.827	0.410
Differences
Mean ± SD	0.158 ± 0.594 mmol/L	− 0.028 ± 0.508 mmol/L
Paired test
Pvalue	0.066	0.699

t Student’s t test, p p value for comparing between the two groups, FBS fasting blood sugar
*highly significant

Back to article page